V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001226 | 330000683 | 1.53 | 58.4 | Curative (C) | 2014-12-07 | 2015-01-10 | Cisplatin | null | Y | 330003109 | CISPLATIN |
| 330001227 | 330000683 | null | 84 | Neo-adjuvant (N) | 2013-10-26 | 2013-11-02 | EW EuroEwing 2012 Arm B VDC | N | N | 330003109 | TRIAL |
| 330001228 | 330000684 | 1.83 | null | Disease modification (D) | null | 2018-08-08 | Trial Unspecified | Y | N | 330003116 | TRIAL |
| 330001229 | 330000685 | 0 | 68.8 | null | 2014-04-26 | 2014-05-03 | CNS GCT II | null | N | 330003117 | NOT MATCHED |
| 330001230 | 330000685 | 1.64 | 82.9 | null | 2015-08-01 | 2015-08-28 | Cisplatin 7 day | N | Y | 330003117 | CISPLATIN |
| 330001231 | 330000686 | 1.43 | null | Curative (C) | 2015-04-30 | 2015-05-18 | Cisplatin | N | N | 330003121 | CISPLATIN |
| 330001232 | 330000687 | null | 61.9 | Curative (C) | 2015-03-15 | 2015-04-01 | Cisplatin 7 day | 02 | Y | 330003122 | CISPLATIN |
| 330001233 | 330000688 | 1.8 | null | Curative (C) | 2016-07-14 | 2016-07-24 | Cisplatin | null | Y | 330003123 | CISPLATIN |
| 330001234 | 330000689 | 1.27 | 34.1 | Curative (C) | 2017-02-25 | 2017-02-26 | NB HRNBL-1 COJEC Ind COURSE A | 01 | N | 330003125 | NOT MATCHED |
| 330001235 | 330000690 | null | 5.7 | Curative (C) | 2015-02-21 | 2015-09-05 | CNS Medbl HR Etoposide | N | N | 330003127 | NOT MATCHED |
| 330001236 | 330000690 | 1.72 | 81 | Palliative (P) | 2016-12-06 | 2016-12-06 | Trial Unspecified | Y | N | 330003127 | TRIAL |
| 330001237 | 330000690 | 1.8 | 91 | Palliative (P) | 2016-06-06 | 2016-06-29 | Cisplatin | N | N | 330003127 | CISPLATIN |
| 330001238 | 330000690 | 1.7 | 66.9 | Palliative (P) | 2016-05-20 | 2016-05-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003127 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001239 | 330000690 | null | null | Curative (C) | null | 2016-05-28 | Cisplatin 7 day | N | Y | 330003127 | CISPLATIN |
| 330001240 | 330000691 | null | null | Curative (C) | 2014-06-11 | 2014-06-25 | Cisplatin | 02 | Y | 330003143 | CISPLATIN |
| 330001241 | 330000691 | null | null | Adjuvant (A) | 2016-08-15 | 2016-08-20 | NB HRNBL-1 BUMEL MAT | Y | N | 330003143 | NOT MATCHED |
| 330001242 | 330009488 | 1.89 | 25.7 | null | 2015-01-16 | 2015-01-29 | Trial Unspecified | Y | Y | 330003145 | TRIAL |
| 330001243 | 330000692 | null | 67 | Curative (C) | 2015-02-24 | 2015-03-15 | Cisplatin 7 day | 02 | N | 330003146 | CISPLATIN |
| 330001244 | 330000692 | null | 61 | Curative (C) | 2013-03-24 | 2013-03-24 | NB Low/Interm risk guidelines Carbo/Etop | 2 | null | 330003146 | NOT MATCHED |
| 330001245 | 330009489 | 0 | 68.2 | Neo-adjuvant (N) | 2014-10-23 | 2014-10-30 | EW EuroEwing 2012 Arm B VDC | Y | N | 330003151 | TRIAL |
| 330001246 | 330009489 | 1.71 | null | Neo-adjuvant (N) | 2013-06-16 | 2013-06-16 | Trial Unspecified | null | Y | 330003151 | TRIAL |
| 330001247 | 330000693 | 1.78 | 78.65 | Palliative (P) | 2014-07-23 | 2014-08-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330003160 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001248 | 330000694 | 0 | 83 | Curative (C) | 2016-03-07 | 2016-03-07 | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB | N | null | 330003163 | NOT MATCHED |
| 330001249 | 330000695 | 1.7 | null | Curative (C) | 2015-08-13 | 2015-08-18 | Cisplatin 7 day | N | Y | 330003165 | CISPLATIN |
| 330001250 | 330000696 | 1.73 | 53 | Curative (C) | 2016-06-07 | 2016-07-09 | Cisplatin | 02 | Y | 330003166 | CISPLATIN |
| 330001251 | 330000696 | 0 | 35.3 | null | 2014-11-02 | 2014-11-16 | Trial Unspecified | Y | N | 330003166 | TRIAL |
| 330001252 | 330000697 | null | 58.8 | Curative (C) | 2015-11-20 | 2015-12-03 | CNS ATRT VCA Vinc/Dactino/Cyclophos + GCSF | N | null | 330003170 | NOT MATCHED |
| 330001253 | 330000698 | 1.8 | 22.8 | Not known (9) | 2015-12-03 | 2015-12-03 | Trial Unspecified | N | N | 330003171 | TRIAL |
| 330001254 | 330000699 | 1.04 | 58.5 | Curative (C) | 2016-06-15 | 2016-06-15 | OST Euramos 1 Closed Trial - Ai | 02 | N | 330003174 | NOT MATCHED |
| 330001255 | 330000700 | 1.69 | 152.7 | Adjuvant (A) | 2018-02-10 | 2018-02-14 | Cisplatin 7 day | N | Y | 330003181 | CISPLATIN |
| 330001256 | 330000701 | 1.7 | 14 | Curative (C) | 2015-06-17 | 2015-06-27 | Cisplatin | 02 | N | 330003183 | CISPLATIN |
| 330001257 | 330000701 | 1.8 | 3 | Neo-adjuvant (N) | 2016-07-15 | 2016-08-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330003183 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001258 | 330000702 | 1.57 | null | Curative (C) | 2014-09-20 | 2014-10-12 | Cisplatin | 02 | Y | 330003189 | CISPLATIN |
| 330001259 | 330000703 | 1.7 | 86 | Curative (C) | 2013-09-04 | 2013-10-04 | Cisplatin 7 day | N | Y | 330003190 | CISPLATIN |
| 330001260 | 330000704 | 1.59 | 11.5 | Palliative (P) | 2017-06-29 | 2017-07-24 | EW EuroEwing 2012 Arm B VDC | N | N | 330003192 | TRIAL |
| 330001261 | 330000705 | 1.67 | 161.8 | Curative (C) | 2015-01-20 | 2015-01-25 | Cisplatin 7 day | N | null | 330003195 | CISPLATIN |
| 330001262 | 330000705 | 1.69 | 55 | Neo-adjuvant (N) | 2015-04-12 | 2015-04-19 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003195 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001263 | 330000706 | null | 94.3 | null | null | 2015-07-21 | AML Interim Guidelines FLA -Ida | N | null | 330003197 | NOT MATCHED |
| 330001264 | 330006434 | 1.74 | 96.3 | Curative (C) | null | 2014-01-02 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330003202 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001265 | 330000707 | 0 | 22.8 | Palliative (P) | null | 2014-02-09 | NB HRNBL-1 Isotretinoin | null | N | 330003203 | NOT MATCHED |
| 330001266 | 330000708 | null | 44 | Curative (C) | 2015-10-31 | 2015-11-19 | Cisplatin | 02 | Y | 330003204 | CISPLATIN |
| 330001267 | 330000708 | 0 | 91.9 | Curative (C) | 2016-04-24 | 2016-04-24 | Trial Unspecified | N | N | 330003204 | TRIAL |
| 330001268 | 330000709 | 1.77 | 15 | Neo-adjuvant (N) | 2016-07-09 | 2016-07-30 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330003214 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001269 | 330000709 | 1.71 | 27.6 | Neo-adjuvant (N) | 2015-01-23 | 2015-03-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003214 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001270 | 330000709 | null | 74.9 | null | 2015-04-28 | 2015-04-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003214 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001271 | 330000710 | 1.8 | 66 | Curative (C) | 2016-08-28 | 2016-08-28 | Trial Unspecified | Y | null | 330003223 | TRIAL |
| 330001272 | 330000711 | null | 60 | Curative (C) | 2015-12-27 | 2016-01-09 | NB HRNBL-1 ch14.18/CHO only (trial) | Y | N | 330003224 | NOT MATCHED |
| 330001273 | 330000712 | 1.77 | 91.9 | Neo-adjuvant (N) | null | 2015-06-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003227 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001277 | 330000715 | 1.62 | 83 | Curative (C) | 2016-06-22 | 2016-07-06 | Cisplatin 7 day | 02 | Y | 330003235 | CISPLATIN |
| 330001278 | 330000716 | 1.71 | 57.05 | Curative (C) | 2013-07-23 | 2013-07-23 | OST Euramos 1 Closed Trial - Ai | N | N | 330003236 | NOT MATCHED |